Among avian retroviruses, Rous sarcoma virus (RSV) has been most thoroughly studied because of its competency in replication and sarcomagenic transformation. The sarcoma gene (src) in RSV codes a protein, p6OBrc (4, 21) , which has protein kinase activity phosphorylating tyrosine residues in target proteins (5, 10) . Recently, we (27) reported that a newly isolated avian sarcoma virus, Y73 (11) , contains a sarcomagenic transforming gene (yas) showing no homology with the src sequence of RSV. Furthermore, a specific protein, p90, was found in Y73-transformed cells and shown to have protein kinase activity, which phosphorylated tyrosine residues in p90 itself and in heavy-chain molecules of immunoglobulin G complexed with p90 (13) . Fujinami sarcoma virus (7) was also recently reported to have a distinct class of transforming gene (8, 16) .
Independent isolates of avian sarcoma viruses RSV and B77 are competent in replication and have virtually the same genome structure: 5' gag pol env src 3' (26) . On the other hand, all avian acute leukemia viruses are defective in replication, deleting the pol and env genes and part of the gag gene, instead of the region containing the transforming gene in the middle of the genome (3, 6, 9, 18, 22) . Since Y73 is a sarcomagenic virus, but is defective in replication (11) , it seemed interesting to determine its genome structure.
In this work, we characterized the Y73 genome by RNase T1 fingerprinting analysis and in vitro translation of the genome RNA. Results showed that the structural features of the Y73 genome are essentially the same as those of genomes of other acute leukemia viruses and that polyprotein p90 is a gene product of the specific sequence (yas), suggesting that p90 is a transforming protein.
MATERLALS AND METHODS
Cells and viruses. Chicken embryo fibroblasts were prepared from C/O or C/BE chicken embryos and cultured as described before (28) . Y73 viral stock was grown as described previously (13) , and Y73-associated virus (YAV) was isolated by two successive limiting dilutions on chicken embryo fibroblasts and confirmed to have no focus-forming ability under the standard agar layer.
Viral preparations were harvested every 12 h and purified by precipitation with ammonium sulfate and by successive discontinuous and continuous sucrose gradient centrifugations as described previously (30) .
Labeling of viral RNA with [32P]phosphate was carried out exactly as described previously (30) .
Preparation of viral RNA. Virion RNA was extracted by proteinase treatment followed by phenol extraction (30) . Virions were disrupted by adding 0.1 volume of 10% sodium dodecyl sulfate in the presence of 100 ,Lg of proteinase K per ml. After incubation for 30 min at 37°C, RNA was extracted three times with phenol-chloroform (6:4) 431 some experiments, RNA containing polyadenylic acid [poly(A)] was separated by passing the preparation through a column of oligodeoxythymidylic acid-cellulose as described before (31) .
Fingerprinting analysis of [32PJRNA. Two-dimensional gel electrophoresis was used for fingerprinting RNase Ti-resistant oligonucleotides. The procedure was essentially as described by Lee and Wimmer (17) . Oligonucleotides separated on gels were extracted with 0.5 ml of water, lyophilized, and digested with RNase A (0.1 mg/ml). The digests were analyzed by electrophoresis at pH 3.5 on DEAE-cellulose paper as described by Barrell (1) .
In vitro translation of viral RNA. mRNA-dependent reticulocyte lysate was prepared as described by Pelham and Jackson (20) and used to translate Y73 RNA as described previously (29) . Each reaction mixture (12 pl) contained 0.2 jlg of viral RNA and 20 ACi of [3S]methionine in addition to the standard reagents. Two microliters of the reaction mixture was used for gel electrophoresis in the buffer described by Laemnmli (15) , and the gels were dried for autoradiography or fluorography. Cells were labeled with [3S]-methionine as described previously (31) , and immunoprecipitation was carried out according to Kessler (14) . (Fig. lb) . The 4.8-kb RNA extracted from the gel sedimented as 26S on sucrose gradient centrifugation (Fig. le) , and the RNA was smaller than those of known defective acute leukemia viruses (3, 6, 12, 18) . On the other hand, 8.5-kb RNA sedimented as 35S, and its mobility in the gel was the same as that of RNA of transformation-defective RSV. From these results, and from the findings that nontransforming YAV isolated by limiting dilution contained only 8.5-kb RNA and that the 4.8-kb component has a specific sequence, as shown in this paper, we concluded that the 4.8-kb RNA species is the genome of Y73 carrying the sarcomagenic transforming gene.
Analysis of Y73 RNA by fingerprinting. The relationship between 4.8-kb and 8.5-kb RNAs was analyzed by fingerprinting RNase T1-resistant oligonucleotides. 32P-labeled 4.8-kb and 8.5-kb RNAs were separated by agarose gel electrophoresis and selected for poly(A)-containing RNA on oligodeoxythymidylic acid-cellulose. The fingerprint of the 8.5-kb RNA (Fig. 2D) showed that the helper 8.5-kb RNA was a single component, and as expected, the fingerprint of 4.8-kb RNA contained the specific oligonucleotides that were missing in that of 8. [32PJRNA of Y73 was fractionated into 26S (A) and 35S (D) fractions, and each fraction was treated with weak alkali to introduce one or two cuts in the RNA molecule, as described previously (27) . Then RNA fragments containing poly(A) were separated on oligodeoxythymidylic acid-cellulose and fractionated into six fractions by sucrose gradient centrifugation. Each fraction was recentrifuged, and the peak fraction was digested with RNase T, and fingerprinted by two-dimensional gel electrophoresis. indicating that 4.8-kb RNA contained the specific nucleotide sequences ( Fig. 2A) . All of the oligonucleotide spots found in the fingerprint of 8.5-kb RNA were detected in that of 4.8-kb RNA, but most of them were minor components. These minor spots were probably contamination of the 4.8-kb RNA fraction with fragments of 8.5-kb RNA. To verify this explanation, each spot was cut out from the gels and quantitated by counting the radioactivity of 32P. Since the accurate length of each oligonucleotide was not known, the ratio of the yield of each oligonucleotide from the 4.8-kb RNA fraction to that of the corresponding spot from 8.5-kb RNA was used to estimate the apparent molar yield of each oligonucleotide, assuming that pure 8.5-kb RNA gave each oligonucleotide in a molar ratio.
In the case of spots specific to 4.8-kb RNA, the yield of oligonucleotides of 8.5-kb RNA which were similar in size was used to calculate the ratio. The results are summarized in Analysis of the nucleotide composition of 22 oligonucleotides originating from 4.8-kb RNA suggested that 11 oligonucleotides were specific and produced in a ratio of 0.8 to 1.2 and that 10 oligonucleotides were shared with YAV 8.5-kb RNA and thus were produced at a ratio of more than 1.4 (Table 2 ). Assuming a random distribution of the oligonucleotides along the genome, the results suggest that about half the 4.8-kb sequence is specific to 4.8-kb RNA.
For determination of the location of the oligonucleotides specific to 4.8-kb RNA within the genome, RNA fragments containing poly(A) were fractionated and purified by sucrose gradient centrifugation, followed by recentrifugation of each fraction and fingerprinting ( Fig. 2B  and C) . Although the 4.8-kb RNA fraction was contaminated with fragments of 8.5-kb RNA, only 22 spots, which were concluded to be produced from 4.8-kb RNA (Table 2) , were followed, and the other spots were ignored. Thus, a tentative oligonucleotide map was constructed (Fig. 3) . YAV 8.5-kb RNA was analyzed similarly (Fig. 2E and F) , and the two oligonucleotide maps were compared. Ten oligonucleotides were common to both RNAs, and 4 of these 10 were eucaryotic cells translates only one gene near the 5' end of polycistronic viral mRNA (19, 21, 25) . In contrast to Pr76, a product with a molecular weight of about 90,000 (p90) was synthesized most efficiently from slightly smaller RNA than 28S (Fig. 4b) . Since fractions of similar sized RNA of YAV did not support detectable synthesis of p90, the results indicate that p90 was coded by the 4.8-kb RNA of Y73. The effect of 7-methyl-GTP, a cap analog, on the synthesis of p90 was tested to know whether p90 was synthesized by intact capped RNA or fragmented RNA (2). As seen in Fig. 5 , the syntheses of p90 and Pr76 were both strongly inhibited by the addition of 7-methyl-GTP. On the other hand, the amount of smaller minor products was not reduced by addition of 7-methyl-GTP. These findings strongly support the idea that p90 is synthesized by intact 4.8-kb RNA which has a cap structure at the 5' terminus and also that smaller products are synthesized by fragmented RNA.
The in vitro product p90 was found to be immunoprecipitated with serum against disrupted virions of B77 (Fig. 5 ). Since this antiserum mainly contained antibody to gag proteins, p90 was suggested to contain amino acid sequences related to gag proteins. This anti-B77 antiserum precipitated p90 from an extract of cells transformed with Y73, and, as seen in Fig.  5 , no detectable difference was observed in the molecular sizes of the in vivo and in vitro products. This strongly suggests that these two p90 proteins are identical. When another antiserum that had no antibody activity against p19 was used, Pr76 and p27 were precipitated from transformed cells, but p90 was not (Fig. 5 ). This result demonstrated that p90 contained the amino acid sequence of p19, but not that of p27. However, this experiment does not exclude the possible presence of a partial sequence of p27 in the p90 molecule.
DISCUSSION
In this paper, we characterized the genome structure of Y73, a newly isolated avian sarcoma virus which, like RSV, induces fibrosarcoma in chickens (11) . The transforming gene (yas) of Y73 was previously characterized as a new type of sarcoma gene with no homology with src of RSV or fps of Fujinami sarcoma virus (27) . In the present study, the yas sequence, which was characterized by specific oligonucleotides, was mapped in the middle portion of the genome, with portions of 1 to 1.5 kb common to the 3' and 5' ends of helper YAV RNA at the two ends. In vitro translation of 4.8-kb RNA has directly shown that a polyprotein of 90,000 daltons (p90) containing p19 but not p27 is a specific translation product. The p90 was translated from a gene near the 5' end of the intact genome RNA containing the cap structure. The presence of an approximately 1.5-kb sequence homologous with the 5' region of YAV RNA suggested that p19 was the N-terminal polypeptide component in p90, because even if a long untranslated region such as 0.5 kb were present in the 5' region, the RNA sequence coding for p19, an N-terminal peptide in Pr76, could be included in the 5' region homologous with YAV RNA. Thus, a polypeptide of about 71,000 daltons should be coded by a specific nucleotide sequence of about 2.5 kb and therefore would be a specific polypeptide. This conclusion was supported by the findings that anti-gag serum that had no anti-p19 activity did not precipitate p90 and that rabbit antiserum against p6Oarc coded by Schmidt-Ruppin strain RSV did not cross-react with p90 (13) .
Since most of the specific sequence in the 4.8-kb genome would be used for p90, p90 seems to be the only polypeptide coded by the Y73 genome. This possibility is consistent with the finding that 4.8-kb RNA is the only species detectable with specific complementary DNA (cDNAya,) in cells transformed with Y73. These considerations strongly suggest that p90 is involved in the mechanism of sarcomagenic transformation of infected cells. This prediction is supported by the finding that p90 detected in cells transformed with Y73 had protein kinase activity for phosphorylation of tyrosine residues in p90 itself and in heavy-chain immunoglobulin G complexed with p90 (13) . However, we did not exclude the possible formation of smaller products coded by the Y73 and undetectable by our methods.
